![](/img/cover-not-exists.png)
446 Docetaxel, Carboplatin and Trastuzumab (TCH) as Neoadjuvant (neoadj) Therapy in Patients (pts) with HER2-positive (HER2+) Operable Breast Cancer (BrCa)
M. Zuradelli, G. Gullo, J. Walshe, A.M. Defrein, J. Healy, R. Kalachand, H. Murray, F. Sclafani, J.P. CrownVolume:
48
Year:
2012
Language:
english
DOI:
10.1016/s0959-8049(12)70511-7
File:
PDF, 59 KB
english, 2012